NTI164
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for NTI164, covering 2022-11-25 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome [Phase 2, Phase 3]